Ulcerative Colitis Clinical Research Trials

Birmingham : University of Alabama at Birmingham

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Birmingham : University of Alabama at Birmingham

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Dothan : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Dothan : Digestive Health Specialists of the Southeast Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Mobile :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Mobile : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mobile : Springhill Memorial Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mobile : Internal Medicine Center, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mobile : Horizon Research Group, Inc.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Casa Grande : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Phoenix :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Phoenix : Investigational Site Number 840057 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Scottsdale : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Sun City : Investigational Site Number 840065 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Tucson : Adobe Clinical Research, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tucson : Adobe Surgery Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Little Rock : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Little Rock : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Los Angeles : Gastrointestinal Bioscience

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Montebello : Paramount Medical Specialty

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Sacramento : Capital Gastroenterology Consultants Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Clinical Applications Laboratories Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Desta Digestive Disease Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Anaheim : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Anaheim :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Anaheim : Anaheim Clinical Trials

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Anaheim : Santarus Clinical Investigational Site 1043

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Glendale : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Glendale : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

La Jolla : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

La Jolla : UCSD Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

La Jolla : UCSD Medical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

La Jolla :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Lakewood : Santarus Clinical Investigational Site 1071

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Los Angeles :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Los Angeles : Cedars-Sinai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Los Angeles : Cedars Sinai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Los Angeles : Investigational Site Number 840031 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Cedars-Sinai Medical Center - Inflammatory Bowel Disease Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Cedars Sinai Medical Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Los Angeles : Santarus Clinical Investigational Site 1051

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mission Hills : Investigational Site Number 840059 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Oakland :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Orange : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Palm Springs : Homan A Zadeh, MD, MPH

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Palm Springs : Homan A Zadeh, MD, MPH

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Rancho Mirage : Hope Square Surgical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

San Diego :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

San Diego : Sharp Rees-Stealy Medical Group

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

San Diego : San Diego Endoscopy Center

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

San Diego : Clinical Application Laboratories, Inc.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

San Diego : Investigational Site Number 840074 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

San Diego : Sharp Rees-Stealy Medical Group

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

San Diego : Santarus Clinical Investigational Site 1003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Diego : Santarus Clinical Investigational Site 1053

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Francisco :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

San Francisco : University of California, San Francisco

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Aurora : University of CO Health Sciences Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lafayette : Gastroenterology of the Rockies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lakewood : Rocky Mountain Gastroenterology Associates P.L.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Arapahoe Gastroenterology Associates P.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lone Tree : South Denver Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pueblo : Lynn Institute of Pueblo

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Denver :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Lafayette : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Lakewood : Investigational Site Number 840030 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Lakewood : Rocky Mountain Gastroenterology Associates

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Lakewood : Rocky Mountain Gastroenterology Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Littleton : Investigational Site Number 840061 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Littleton : Santarus Clinical Investigational Site 1063

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Thornton : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Bristol : Santarus Clinical Investigational Site 1028

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Giolford : Endoscopy Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Guilford : Endoscopy Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Guilford : Endoscopy Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, PC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, PC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamden : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Hamden : Pfizer Investigational Site Updated

Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Hamden : Medical Research Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Gastroenterology Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Endoscopy Center of Connecticut, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Hamden : Santarus Clinical Investigational Site 1018

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hartford :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Hartford : Connecticut Children's Medical Center

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

New Haven :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Gainesville : University of Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : East Coast Institute for Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : Borland-Groover Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Jacksonville : University of Florida, Jacksonville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Melbourne : Osler Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Miami : University of Miami Miller School of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Smyrna Beach : United Medical Research Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Compass Research LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Orlando : Internal Medicine Specialists

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates

Mild to Moderate Ulcerative Colitis

Port Orange : Accord Clinical Research, LLC an Accel Research Site

Ulcerative Colitis

Tampa : University of South Florida

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tampa : West Wind'r Research & Development, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boynton Beach : Investigational Site Number 840054 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Boynton Beach : Santarus Clinical Investigational Site 1035

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Clearwater : Investigational Site Number 840050 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Cooper City : South Broway Ebdiscopy

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Crystal River : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Gainesville :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Hialeah : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Hialeah : Digestive Medical Associates Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Hollywood : Southern Clinical Research Consultants

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Inverness : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Jacksonville : Santarus Clinical Investigational Site 1045

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Largo : Santarus Clinical Investigational Site 1001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Maitland : MNH Surgical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Maitland : Center for Advanced Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Maitland : Investigational Site Number 840041 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Maitland : Santarus Clinical Investigational Site 1024

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miami :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Miami : Investigational Site Number 840003 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Miami : Jackson Memorial Hospital

Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease

Miami : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Miramar : Investigational Site Number 840008 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Miramar : Santarus Clinical Investigational Site 1013

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Naples : Gastroenterology Group of Naples

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Naples : Investigational Site Number 840044 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

North Miami Beach : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Orlando : Citrus Ambulatory Surgery Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Orlando : Internal Medicine Specialists

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Orlando : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Palm Harbor : Advanced Gastroenterology Associates Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Port Orange : Santarus Clinical Investigational Site 1029

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tampa : West Wind'r Research & Development, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Winter Park : Investigational Site Number 840048 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Winter Park : Santarus Clinical Investigational Site 1010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Winter Park : Shafran Gastroenterology Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Zephyrhills : Florida Medical Clinic

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Zephyrhills : Santarus Clinical Investigational Site 1002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Atlanta : Atlanta Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Decatur : Atlanta Center for Gastroenterology, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Newnan : Digestive Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Savannah : St. Joseph's/Candler Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Snellville : DLW Research System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Alpharetta : Georgia Endoscopy Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Athens : Tri-County Research Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Atlanta :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Atlanta : GI Consultants

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Atlanta : GI Consultants

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Atlanta :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Atlanta : GI Consultants

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Atlanta :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Augusta : Investigational Site Number 840073 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Decatur : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Decatur : Atlanta Center for Gastroenterology, P.C.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Decatur : Santarus Clinical Investigational Site 1050

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Decatur : The Atlanta Center for Gastroenterology Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Johns Creek : Emory Healthcare Heart Center

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Macon : Gastroenterology Associates of Central Georgia, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Marietta : Santarus Clinical Investigational Site 1085

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Savannah : Investigational Site Number 840053 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Suwanee : Johns Creek Diagnostic Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Johns Creek Diagnostic Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Suwanee : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Suwanee : Atlanta Gastroenterology Associates

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Boise :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Chicago : Rush University Medical Center - Treatment Research Center

Dysbiosis in inflammatory bowel disease.

Urbana : Carle Clinic Association P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Arlington Heights : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Arlington Heights : NCH Medical Group Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Chicago :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Chicago : Investigational Site Number 840001 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Chicago : Santarus Clinical Investigational Site 1075

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Oak Lawn : Southwest Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Oak Lawn : Investigational Site Number 840005 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Oak Lawn : Santarus Clinical Investigational Site 1065

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Indianapolis : Santarus Clinical Investigational Site 1058

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Clive : Iowa Digestive Disease Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Digestive & Liver Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Clive : Santarus Clinical Investigational Site 1008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Davenport : Gastrointestinal Clinic of Quad Cities Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Kansas City : University Of Kansas

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Topeka : Cotton O'Neil Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Kansas City : Investigational Site Number 840062 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Topeka : Cotton-O'Neil Clinical Research Center, Digestive Health

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Wichita : Investigational Site Number 840033 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Wichita : Professional Research Network of Kansas Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Lexington : University of Kentucky Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Louisville : University Of Louisville

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Baton Rouge : Gastroenterology Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Hammond : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hammond : Investigational Site Number 840078 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Metairie : Santarus Clinical Investigational Site 1034

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Monroe : Delta Research Partners LLC

Evaluating the Safety, Pharmacokinetics and Efficacy of GS-5745 in Subjects With Moderate to Severe Ulcerative Colitis

New Orleans :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Shreveport : Santarus Clinical Investigational Site 1032

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Portland :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Baltimore : University of Maryland Medical Group

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : Metropolitan Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chevy Chase : MGG Group Co., Inc., Chevy Chase Clinical Research

Ulcerative Colitis and Crohn’s Disease (IBD) Research Study

Prince Frederick : Shah Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Annapolis : Santarus Clinical Investigational Site 1044

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Baltimore : University of Maryland Medical Center for Children

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Chevy Chase :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Chevy Chase : Chevy Chase Clinical Research

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Chevy Chase : Santarus Clinical Investigational Site 1057

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hollywood : Investigational Site Number 840049 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Hollywood : Santarus Clinical Investigational Site 1012

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Prince Frederick : Shah Associates, MD, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Boston : Boston Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Boston : Massachusetts General Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Agawam : Gerald McPherson

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Boston :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Boston : Boston Medical Center

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

Worcester :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Dearborn : The Center for Clinical Studies

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Troy : Center for Digestive Health

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Wyoming : Gastroenterology Associates of Western Michigan, P.L.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Ann Arbor :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Berkley : Dr. Jason Bozdin, M.D. Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Chesterfield : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Chesterfield : Clinical Research Institute of Michigan

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Chesterfield : Santarus Clinical Investigational Site 1016

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Detroit :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Novi : Santarus Clinical Investigational Site 1081

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Troy : Center for Digestive Health

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Troy : Center for Digestive Health

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Troy : Center for Digestive Health

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Utica : Utica Surgery Center (Endoscopy ONLY)

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Wyoming : Investigational Site Number 840011 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Wyoming : Santarus Clinical Investigational Site 1015

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Wyoming : Gregory Cammel, MD PLC Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Ypsilanti : Santarus Clinical Investigational Site 1068

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plymouth : Minnesota Gastroenterology, P.A.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Rochester : Mayo Clinic

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Minneapolis :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Rochester :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Rochester : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Rochester : Mayo Clinic

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Rochester : Mayo Clinic

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Rochester : Santarus Clinical Investigational Site 1074

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Rochester : Mayo Clinic

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rochester :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Saint Paul :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Jackson : GI Associates and Endoscopy Center Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Ocean Springs : Investigational Site Number 840060 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Kansas City : Truman Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Mexico : Center for Digestive and Liver Diseases, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : Washington University

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

St. Louis : St. Louis Center for Clinical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Columbia : Surgery Center of Columbia

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Hannibal : Hannibal Regional Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mexico : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Mexico : Center for Digestive & Liver Disease, Inc.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Audrain Medical Center

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mexico : Investigational Site Number 840024 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Mexico : Center for Digestive and Liver Disease

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Boys Town :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Lebanon : Dartmouth-Hitchcock Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lebanon : Santarus Clinical Investigational Site 1061

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Manchester :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Morristown : Affiliates in Gastroenterology PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New Brunswick : University of Medicine and Dentistry of New Jersey-NJMS

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Egg Harbor Township : AGA Clinical Research Associates, LLC

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Marlton : South Jersey Gastroenterology

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Mays Landing :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Morristown :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Teaneck : Investigational Site Number 840080 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Vineland : The Gastroenterology Group of South Jersey

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Bayside : Hepatobiliary Associates of New York

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Cheektowaga : Digestive Health Physician

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Merrick : Long Island Gastroenterology Group, P.C.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : The Rockefeller University Hospital

Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity

New York : Present Chapman Marion Steinlauf MD PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

New York : New York Presbyterian Hospital

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsford : Kim, Chung MD (Private Practice)

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Rochester : University of Rochester

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Setauket : Long Island Digestive Disease Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Stony Brook : SUNY Stony Brook University Medical Center Updated

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Syracuse : Syracuse Gastroenterological Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Brooklyn :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Buffalo :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Cheektowaga : Santarus Clinical Investigational Site 1021

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Great Neck : Nassau Gastroenterology Associates

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Nassau Gastroenterology Associates, PC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates, LLP

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Great Neck : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Great Neck : Investigational Site Number 840051 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Great Neck :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Great Neck : Santarus Clinical Investigational Site 1072

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Great Neck : Long Island Clinical Research Associates, LLP

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Great Neck :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Lake Success : Santarus Clinical Investigational Site 1067

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mineola :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

New Hyde Park :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

New York :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

New York : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

New York : Santarus Clinical Investigational Site 1031

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

New York : Research Associates of New York Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Poughkeepsie : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Stony Brook :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Syracuse :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Chapel Hill : University of North Carolina at Chapel Hill

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlotte : PMG Research of Charlotte

Is Ulcerative Colitis (UC) part of your daily life?

Charlotte : Charlotte Gastroentology and Hepatology, P.L.L.C

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Elkin : Northwest Piedmont Clinical Research, Inc.

An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease

Elkin : Northwest Piedmont Clinical Research, Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Morganton : Burke Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Morrisville : Clinical Trials of North Carolina

A Phase 2, Randomized, Double-Blind, Parallel, Placebo-Controlled, Proof-of-Concept Study to Assess the Efficacy, Safety, and Tolerability of ASP3291 in Patients With Active Ulcerative Colitis

Raleigh : Multi-Specialty Research Associates of NC

Do you have ulcerative colitis in remission?

Raleigh : Wake Research Associates

Struggling with Ulcerative Colitis?

Salisbury : PMG Research of Salisbury

Is Ulcerative Colitis (UC) part of your daily life?

Chapel Hill :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Chapel Hill :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Charlotte : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Davidson : Carolina Digestive Health Associates Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Durham :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Greensboro : LeBauer Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greensboro : LeBauer Research Associates, P.A.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greensboro : LeBauer HealthCare

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Greenville : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Greenville : Carolina Research - Carolina Digestive Diseases

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Jacksonville : Investigational Site Number 840018 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Rocky Mount : Site Reference ID/Investigator# 103618

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Wilmington : Santarus Clinical Investigational Site 1073

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Cincinnati : Consultants for Clinical Research Inc.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Dayton : Dayton Science Institute

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Cincinnati : Investigational Site Number 840046 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Cincinnati :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Cincinnati : Santarus Clinical Investigational Site 1080

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Cincinnati :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Cleveland : Santarus Clinical Investigational Site 1078

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Columbus : Investigational Site Number 840006 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Columbus : Remington-Davis, Inc.

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Dayton : Santarus Clinical Investigational Site 1082

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mentor : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Tulsa : Options Health Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Norman : Central Sooner Research Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Oklahoma City :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Oklahoma City : Oklahoma Foundation for Digestive Research

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Oklahoma City : Oklahoma Foundation for Digestive Research Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Tulsa : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Tulsa : Options Health Research Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Tulsa : Gastroenterology United Tulsa Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Portland : The Oregon Clinic-West Hills Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pittsburgh : University of Pittsburgh Medical Center - Cancer Centers

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Danville :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Lancaster : Regional Gastroenterology Associates of Lancaster, Ltd.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Lancaster : Santarus Clinical Investigational Site 1064

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Philadelphia :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Philadelphia : University of Pennsylvania

Study of Cimzia for the Treatment of Ulcerative Colitis

Phoenixville : Investigational Site Number 840045 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Sayre : Donald Guthrie Foundation for Education and Research

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Sayre : Investigational Site Number 840022 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Sayre : Santarus Clinical Investigational Site 1006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Charleston : Medical University Of SC CAR

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Greenville :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Germantown : Gastroenterology Center of the MidSouth, PC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Nashville : Vanderbilt University Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Germantown : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Germantown : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Germantown : Memphis Gastroenterology Group Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Hermitage : Associated Endoscopy

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hermitage : Hermitage Imaging

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hermitage : Associates in Gastroenteroogy

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Knoxville :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Memphis :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Nashville : Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

Nashville : Nashville Medical Research Institute

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Austin : Austin Gastroenterology, PA

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Gastroenterology Consultants

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Baylor College Of Medicine

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Jacon Medical Research Associates

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Houston : Bayou City Research, Ltd.

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Digestive Health Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

San Antonio : Stone Oak Research Foundation

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Austin : Professional Quality Research, Inc.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Austin : Austin Gastroenterology PA/Austin Endoscopy Center II

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Austin : Santarus Clinical Investigational Site 1059

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Dallas :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Dallas : Dallas VA Medical Center

Exacerbating Factors in Inflammatory Bowel Disease

Dallas : Dallas VA Medical Center Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Fort Worth :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Houston : Gastroenterology Consultants, P.A.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Houston : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Houston : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Houston : Santarus Clinical Investigational Site 1004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Houston : Santarus Clinical Investigational Site 1039

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Houston : Santarus Clinical Investigational Site 1019

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Humble : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Humble : Investigational Site Number 840072 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Laredo : Investigational Site Number 840082 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Pasadena Gastroenterology Associates, P.A. dba Digestive Health Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Pasadena : Investigational Site Number 840019 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Pasadena : Santarus Clinical Investigational Site 1005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

San Antonio : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

San Antonio : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Sugar land : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Sugar Land : Investigational Site Number 840038 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

The Woodlands : Santarus Clinical Investigational Site 1048

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Tyler : Digestive Health Specialists of Tyler

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tyler : Digestive Health Specialists of Tyler

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Sandy : Granite Peaks Gastroenterology

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lancaster : Santarus Clinical Investigational Site 1014

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ogden : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ogden : Santarus Clinical Investigational Site 1020

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Salt Lake City : Alpine Medical Group

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Wasatch Clinical Research

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Wasatch Endoscopy Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Salt Lake City : Wasatch Clinical Research

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Salt Lake City : Alpine Medical Group

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Salt Lake City : Wasatch Endoscopy Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Sandy : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

West Jordan : RGL Medical Services

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Burlington :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Charlottesville : University of Virginia Health System

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Chesapeake : Gastroenterology Associates of Tidewater

A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.

Fairfax : Gastroenterology Associates of Northern Virginia

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Norfolk : Digestive and Liver Disease Specialist Ltd

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Richmond : Hunter Holmes McGuire VA Medical Center

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Charlottesville :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Charlottesville : Investigational Site Number 840068 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Chesapeake : Santarus Clinical Investigational Site 1038

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Christiansburg : Santarus Clinical Investigational Site 1025

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Fairfax :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Norfolk :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Richmond : Investigational Site Number 840079 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Edmonds : Puget Sound Medical Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Seattle :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Seattle : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Seattle : University of Washington

Study of Cimzia for the Treatment of Ulcerative Colitis

Madison : Pharmaseek, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Medical College Of Wisconsin

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Madison :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Madison : Santarus Clinical Investigational Site 1036

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Milwaukee :

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Milwaukee : Center for Digestive Health

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Milwaukee : Center for Digestive Health

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Milwaukee : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Milwaukee : Center for Digestive Health

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Milwaukee : Wisconsin Center for Advanced Research Updated

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

Wauwatosa : Investigational Site Number 840064 Updated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Adelaide : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Adelaide : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Bankstown : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Concord : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Fitzroy :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Garran :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Herston : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Herston : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Parkville :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Prahran : Research Site

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Prahran : Research Site

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Innsbruck : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Ried im Innkreis : Site Reference ID/Investigator# 66064

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

St Veit an der Glan : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

St. Poelten : Site Reference ID/Investigator# 66188

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Wien : AKH Wien

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Wien : Pfizer Investigational Site Updated

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Bonheiden : Site Reference ID/Investigator# 61091

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bonheiden : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bonheiden : Imelda

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

Brussels : Site Reference ID/Investigator# 61093

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Brussels : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Brussels : Pfizer Investigational Site Updated

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Gent : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Gent : UZ Gent

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

Ghent : Site Reference ID/Investigator# 61092

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ghent : Site Reference ID/Investigator# 61089

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Kortrijk : Site Reference ID/Investigator# 63843

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Leuven : Site Reference ID/Investigator# 61096

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Leuven : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Leuven : UZ Leuven

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Leuven : UZ Leuven

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Leuven : Pfizer Investigational Site Updated

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Leuven :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Leuven : Pfizer Investigational Site Updated

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Leuven :

Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Leuven : UZ Leuven

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Leuven : UZ Leuven

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

LiÃ¨ge : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Liege : Site Reference ID/Investigator# 61094

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Roeselare : Site Reference ID/Investigator# 61090

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Pleven : Santarus Clinical Investigational Site 4003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plovdiv : Santarus Clinical Investigational Site 4004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Plovdiv : Santarus Clinical Investigational Site 4009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ruse : Santarus Clinical Investigational Site 4008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Sofia : Santarus Clinical Investigational Site 4005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4011

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Sofia : Santarus Clinical Investigational Site 4001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Calgary : Site Reference ID/Investigator# 61408

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Calgary : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Calgary : Santarus Clinical Investigational Site 2007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Guelph : Site Reference ID/Investigator# 64422

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Halifax : Site Reference ID/Investigator# 61406

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Halifax : Santarus Clinical Investigational Site 2008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hamilton : Site Reference ID/Investigator# 61407

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Site Reference ID/Investigator# 61405

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

London : London Health Science Center - University Hospital

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

London : London Health Science Center - Victoria Hospital

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

London : Santarus Clinical Investigational Site 2004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

London : Santarus Clinical Investigational Site 2005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

London :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Montreal : Santarus Clinical Investigational Site 2009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ottawa : Santarus Clinical Investigational Site 2010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Quebec : Santarus Clinical Investigational Site 2006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saskatoon : Site Reference ID/Investigator# 61762

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Sherbrooke : Santarus Clinical Investigational Site 2001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Toronto : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Toronto : Toronto Digestive Disease Associates

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Toronto :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Vancouver : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vaughan : Santarus Clinical Investigational Site 2002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Victoria : Site Reference ID/Investigator# 61409

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Winnipeg : Site Reference ID/Investigator# 61403

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Winnipeg : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Winnipeg : Santarus Clinical Investigational Site 2003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Beijing :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Chengdu :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Guangzhou :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Hefei :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Shanghai :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Wuhan :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Xian :

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Zagreb :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Hradec Kralove : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hradec Kralove : Hepato-Gastroenterologie HK, s.r.o.

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hradec Kralove : Santarus Clinical Investigational Site 3006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hradec Kralove : Santarus Clinical Investigational Site 3001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Hradec Kralove :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Labem : Santarus Clinical Investigational Site 3005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Nachod :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Olomouc : Santarus Clinical Investigational Site 3003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ostrava - Poruba :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Prague : Santarus Clinical Investigational Site 3009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha : Santarus Clinical Investigational Site 3007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha : Santarus Clinical Investigational Site 3004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Praha 4 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Praha 7 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Tabor : Santarus Clinical Investigational Site 3002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Usti nad Labem : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Usti nad Orlici : Santarus Clinical Investigational Site 3010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Valasske Mezirici : Santarus Clinical Investigational Site 3011

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Zlin :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Ã…rhus C : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Aalborg : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Aalborg : Aalborg Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Aalborg C : Site Reference ID/Investigator# 61117

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Aarhus :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Allerod : Noreba

Trial on Profermin and Fresubin in Ulcerative Colitis

Copenhagen : Site Reference ID/Investigator# 61118

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Herlev : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hvidovre : Site Reference ID/Investigator# 61119

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Hvidovre : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

KÃ¸ge : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Odense : Odense University Hospital

Adalimumab in the Treatment of Chronic Pouchitis

Odense C : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Odense C : Odense University Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : West Tallinn Central Hospital Internal Diseases Clinic

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tallinn : X-Ray Unit, East Tallin Central Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tallinn : ECG Unit, East Tallinn Central Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Tallinn : X-Ray Unit, East Tallinn Central Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : ECG Unit, East Tallinn Central Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Tallinn : Santarus Clinical Investigational Site 8001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lahti : Site Reference ID/Investigator# 63292

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Amiens Cedex 1 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Caen Cedex 9 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Grenoble Cedex 09 : Site Reference ID/Investigator# 61055

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lille : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Lille Cedex : Site Reference ID/Investigator# 61059

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Nantes Cedex : Site Reference ID/Investigator# 61056

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Nice Cedex 3 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Paris cedex 12 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Pessac Cedex : Site Reference ID/Investigator# 63463

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Pessac Cedex : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Reims : Site Reference ID/Investigator# 61057

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

St. Priest en Jarez : Site Reference ID/Investigator# 61063

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Toulouse Cedex 9 : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vandoeuvre les Nancy : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vandoeuvre les Nancy Cedex : Site Reference ID/Investigator# 63462

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Berlin : Site Reference ID/Investigator# 61064

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Berlin : Charité Campus Benjamin Franklin, Medizinische Klinik I

Endomicroscopy in Ulcerative Colitis

Berlin : Pfizer Investigational Site Updated

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Dachau : Site Reference ID/Investigator# 64222

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Erlangen : Department of Medicine I, University of Erlangen-Nuremberg

Endomicroscopy in IBD Patients

Frankfurt : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Halle/ Saale : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hamburg : Site Reference ID/Investigator# 61069

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Hamburg : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Hannover :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Heidelberg : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Herne : Site Reference ID/Investigator# 61066

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Jena : Friedrich-Schiller-Universität Jena, Klinik für Innere Medizin II

Endomicroscopy in Ulcerative Colitis

Kiel : Universitaetsklinikum Schleswig-Holstein, Campus Kiel

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Lübeck :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Luneburg : Klinikum Luneburg/Abteilung Gastroenterologie

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Mainz : Johannes Gutenberg-Universität Mainz, I. Med. Klinik und Poliklinik

Endomicroscopy in Ulcerative Colitis

Minden : Site Reference ID/Investigator# 61065

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Minden :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Muenster : Site Reference ID/Investigator# 61067

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ulm : Universitaetsklinikum Ulm

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Ulm : Universitaetsklinikum Ulm

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

ULM :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Athens : Site Reference ID/Investigator# 63983

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Athens : Site Reference ID/Investigator# 63984

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Athens : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Haidari : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Heraklion : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Larissa : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Piraeus : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bekescsaba : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bekescsaba : Santarus Clinical Investigational Site 5010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Budapest :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Budapest : Santarus Clinical Investigational Site 5008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest : Santarus Clinical Investigational Site 5009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Budapest :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Debrecen : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Debrecen :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Debrecen : Santarus Clinical Investigational Site 5001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

GYR :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Gyula :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Gyula : Santarus Clinical Investigational Site 5003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kaposvar : Santarus Clinical Investigational Site 5004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Miskolc : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Miskolc : Santarus Clinical Investigational Site 5002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Mosonmagyarovar : Santarus Clinical Investigational Site 5006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Pecs : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Pecs : Santarus Clinical Investigational Site 5011

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szeged : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Szeged : Santarus Clinical Investigational Site 5005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szekszard : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Vac : Santarus Clinical Investigational Site 5007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Dublin 24 : Site Reference ID/Investigator# 65987

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Dublin 4 : Site Reference ID/Investigator# 65988

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Dublin 9 : Site Reference ID/Investigator# 65989

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Be'er Sheva : Site Reference ID/Investigator# 64203

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Haifa :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Jerusalem : Site Reference ID/Investigator# 64204

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Jerusalem :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Petach Tikva : Site Reference ID/Investigator# 64206

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ramat-gan :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Tel Aviv :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Tel Hashomer : Site Reference ID/Investigator# 64202

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bologna : Site Reference ID/Investigator# 61112

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Bologna : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Crema : Ospedale Maggiore di Crema, Endoscopy and Gastroenterology Division

Endomicroscopy in Ulcerative Colitis

Firenze : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Milano : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Milano : European Institute of Oncology, Division of Endoscopy

Endomicroscopy in Ulcerative Colitis

Padova : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Palermo : Site Reference ID/Investigator# 61108

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Roma : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Rome : Site Reference ID/Investigator# 61115

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rome : Site Reference ID/Investigator# 61104

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rozzano : Site Reference ID/Investigator# 61111

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Rozzano MI : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bunkyo-ku : Tokyo Medical and Dental University Updated

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

Chikushino : Fukuoka University Chikushi Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Chikushino : Fukuoka University Chikushi Hospital

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Fukuoka : Kurume University Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Hokkaido : Sapporo higashi tokushukai hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Osaka : Osaka City University Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Sendai : National Hospital Organization Sendai Medical Center

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Sendai : National Hospital Organization Sendai Medical Center

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Takatsuki-shi : Osaka Medical College Hospital

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Takatsuki-shi : Osaka Medical College Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Gyunggi-do : Hanyang Univ. Guri Hospital

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Seoul : Kyung Hee University Hospital

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Seoul : Kyung Hee University Medical Center

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Seoul : Kangbuk Samsung Hospital, Sungkyunkwan University

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Seoul : Severance Hospital

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Wonju :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Riga : Santarus Clinical Investigational Site 8103

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Riga : Santarus Clinical Investigational Site 8102

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Riga : Santarus Clinical Investigational Site 8101

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kaunas : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Kaunas : Santarus Clinical Investigational Site 8202

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Klaipeda : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Siauliai : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Vilnius : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Vilnius : Santarus Clinical Investigational Site 8203

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Vilnius : Santarus Clinical Investigational Site 8201

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Amsterdam : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Amsterdam : Academic Medical Center

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Amsterdam : Pfizer Investigational Site Updated

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

Leiden : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Maastricht : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Rotterdam : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Auckland :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Christchurch :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Hamilton :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Lower Hutt :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Milford : Shakespeare Specialist Group

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Hamar : Site Reference ID/Investigator# 62364

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Oslo : Site Reference ID/Investigator# 62362

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Oslo : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

TromsÃ¸ : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bialystok :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Czestochowa :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Elblag : Santarus Clinical Investigational Site 6003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Katowice :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Krakow : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Krakow : Santarus Clinical Investigational Site 6001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Lodz : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Lodz :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Lublin : Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rzeszow : Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Rzgowska : Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Sopot : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Sopot : Santarus Clinical Investigational Site 6002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Szczecin : Santarus Clinical Investigational Site 6006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warsaw : VBL Investigative Site

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis

Warszawa : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Warszawa : Santarus Clinical Investigational Site 6004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warszawa : Santarus Clinical Investigational Site 6008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Warszawa : Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Warszawy : Santarus Clinical Investigational Site 6005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Wieliczka : Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Wroclaw : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Faro : Site Reference ID/Investigator# 61100

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lisbon : Site Reference ID/Investigator# 61102

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lisbon : Site Reference ID/Investigator# 61101

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Porto : Site Reference ID/Investigator# 61098

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Ponce : Pharmaseek, LLC

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Lipetsk : Santarus Clinical Investigational Site 9016

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Moscow :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Moscow : Santarus Clinical Investigational Site 9010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Moscow : Santarus Clinical Investigational Site 9005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Nizhny Novgorod : Santarus Clinical Investigational Site 9004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ryazan : Santarus Clinical Investigational Site 9003

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saint Petersburg : Santarus Clinical Investigational Site 9014

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saint Petersburg : Santarus Clinical Investigational Site 9013

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saint Petersburg : Santarus Clinical Investigational Site 9008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Saratov : Santarus Clinical Investigational Site 9009

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

St Petersburg : Santarus Clinical Investigational Site 9001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Stavropol : Santarus Clinical Investigational Site 9007

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Ufa : Santarus Clinical Investigational Site 9006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Volgograd : Santarus Clinical Investigational Site 9017

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Banska Bystrica : DFNsP Banska Bystrica

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Bratislava : Gastroenterological Centre Thalion

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Limbova 2 : Gastroenterologicka ambulancia

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Martin : Univerzitna nemocnica Martin

Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

Nitra : Jessenius - diagnosticke centrum a.s.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : Kardiocentrum Nitra s.r.o.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : KM Management spol. s.r.o.

A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis

Nitra : Jessenius - diagnosticke centrum a.s.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Nitra : Kardiocentrum Nitra s.r.o.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Nitra : KM Management spol. s r.o.

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Nitra : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Nitra :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Nitra : Kardiocentrum Nitra s.r.o.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nitra : KM Management spol. s.r.o.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nitra : Jessenius - diagnosticke centrum a.s.

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Nove Mesto nad Vahom : Lexicon Investigational Site

A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Presov :

Efficacy and Safety Study of RPC1063 in Ulcerative Colitis

Badalona - Barcelona : Site Reference ID/Investigator# 61087

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Barcelona : Site Reference ID/Investigator# 61086

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Barcelona : Site Reference ID/Investigator# 61083

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Cordoba : Site Reference ID/Investigator# 61085

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Madrid : Site Reference ID/Investigator# 63988

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Madrid : Site Reference ID/Investigator# 61082

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Santiago de Compostela : Site Reference ID/Investigator# 61088

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Gothenburg : Site Reference ID/Investigator# 61071

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Linkoping : Site Reference ID/Investigator# 61073

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Lund : Site Reference ID/Investigator# 61072

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Skovde : Site Reference ID/Investigator# 65583

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Stockholm : Site Reference ID/Investigator# 65586

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Stockholm : Södersjukhuset

A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis

Basel : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Bern : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

St. Gallen : Site Reference ID/Investigator# 66183

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Zurich : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Crimea : Santarus Clinical Investigational Site 7010

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Donetsk : Santarus Clinical Investigational Site 7002

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kharkiv : Santarus Clinical Investigational Site 7004

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kharkiv : Santarus Clinical Investigational Site 7001

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kyiv : Santarus Clinical Investigational Site 7006

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Kyiv : Santarus Clinical Investigational Site 7008

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Odessa :

A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis

Vinnytsia : Santarus Clinical Investigational Site 7005

Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA

Birmingham :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Birmingham : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Blackpool : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Coventry :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Coventry : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Derby : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Gloucester : Site Reference ID/Investigator# 62367

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Liverpool :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Liverpool : Royal Liverpool University Hospital

Rituximab in Ulcerative Colitis

London : Site Reference ID/Investigator# 62567

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

London : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Manchester : Research Site

A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis

Newcastle Upon Tyne :

Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis

Oxford : Site Reference ID/Investigator# 61046

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Southampton : Site Reference ID/Investigator# 62568

A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting

Wigan :

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

Worthing : Worthing Hospital

Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)

Ulcerative Colitis Clinical Trials

Alabama

Arizona

Arkansas

California

Colorado

Connecticut

Florida

Georgia

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Nebraska

New Hampshire

New Jersey

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Vermont

Virginia

Washington

Wisconsin

Australia

Austria

Belgium

Bulgaria

Canada

China

Croatia

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Israel

Italy

Japan

Korea, Republic of

Latvia

Lithuania

Netherlands

New Zealand

Norway

Poland

Portugal

Puerto Rico

Russian Federation

Slovakia

Spain

Sweden

Switzerland

Ukraine

United Kingdom